Some doctors are researching if artificial intelligence can predict and prevent a stroke in people without a history of heart ...

Rhythm Technologies, Inc. (NASDAQ:IRTC) is one of the 10 Stocks with Huge Catalysts on the Horizon. The FDA clearance for the ...

The FDA has granted clearance for the CardioTag device to assess cardiac function and improve patient outcomes across various healthcare settings.

Rhythm (Nasdaq: IRTC) announced a strategic partnership with Lucem Health to accelerate undiagnosed arrhythmia detection.

The warning letter detailed multiple issues with iRhythm's Zio AT mobile cardiac telemetry device and resulted in shares of the company to sell off from $120 to $100. iRhythm responded in a recent ...

Cardiosense, a medical AI company transforming cardiovascular disease management, today announced that the U.S. Food and Drug ...

With funding from the American Heart Association, UM researchers are building a wearable sensor called INSIGHT-CPR to help ...

Zinger Key Points FDA clears iRhythm's first 510 (k) submission for Zio AT device; second approval expected soon. Zio AT provides mobile cardiac telemetry for up to 14 days, aiding in ECG monitoring.

A tiny implantable heart device is changing lives for patients with HFpEF heart failure. Scripps La Jolla is among 65 ...

Overview of Cardiovascular Monitoring And Diagnostic Devices MarketThe cardiovascular monitoring and diagnostic devices ...

Philips is recalling the software associated with its mobile cardiac outpatient telemetry devices after 109 patient injuries and two patient deaths, a Jan. 13 FDA recall notice said.